
PRESS RELEASES
PRESS RELEASES
Epify progresses colorectal cancer program and files first patent application on a broad range of applications
Epify signs agreement with Maastricht University to validate colorectal cancer biomarkers for early detection
Epify Strengthens Management Team by Appointing Leander Van Neste as Chief Scientific Officer
Epify has been featured in a Genomeweb article
"Dutch Startup Epify Raises €500,000 in Seed Funding".
Epify BV Raises 500,000 Euros in Seed Round to Develop Epigenetic Biomarkers for Cancer Diagnosis and Personalized Treatment